NO318758B1 - Fremgangsmate for enzymatisk opplosning av en racemisk blanding av stereospesifikke GABA-T-inhibitorer. - Google Patents

Fremgangsmate for enzymatisk opplosning av en racemisk blanding av stereospesifikke GABA-T-inhibitorer. Download PDF

Info

Publication number: NO318758B1
Authority: NO; Norway
Prior art keywords: gaba; formula; compound; enantiomer; phenylacetyl
Prior art date: 1992-07-17

Application number

NO19950157A

Other languages

English (en)

Norwegian (no)

Other versions

NO950157D0 (no

NO950157L (no

Inventor

Alexy Leonid Margolin

Original Assignee

Merrell Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-17

Filing date

1995-01-16

Publication date

2005-05-02

1995-01-16 Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc

1995-01-16 Publication of NO950157D0 publication Critical patent/NO950157D0/no

1995-01-16 Publication of NO950157L publication Critical patent/NO950157L/no

2005-05-02 Publication of NO318758B1 publication Critical patent/NO318758B1/no

Links

239000000203 mixture Substances 0.000 title claims abstract description 10
230000002255 enzymatic effect Effects 0.000 title claims abstract description 5
238000000034 method Methods 0.000 title claims description 17
239000003112 inhibitor Substances 0.000 title abstract description 7
230000000707 stereoselective effect Effects 0.000 title abstract description 4
102100035923 4-aminobutyrate aminotransferase, mitochondrial Human genes 0.000 title description 7
101710115046 4-aminobutyrate aminotransferase, mitochondrial Proteins 0.000 title 1
108010073038 Penicillin Amidase Proteins 0.000 claims abstract description 12
150000001875 compounds Chemical class 0.000 claims description 23
238000002360 preparation method Methods 0.000 claims description 4
239000012044 organic layer Substances 0.000 claims description 2
239000010410 layer Substances 0.000 claims 2
239000003960 organic solvent Substances 0.000 claims 1
229960003692 gamma aminobutyric acid Drugs 0.000 abstract description 42
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract description 21
PJDFLNIOAUIZSL-UHFFFAOYSA-N vigabatrin Chemical compound C=CC(N)CCC(O)=O PJDFLNIOAUIZSL-UHFFFAOYSA-N 0.000 abstract description 10
108090000340 Transaminases Proteins 0.000 abstract description 3
OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract description 2
102000003929 Transaminases Human genes 0.000 abstract description 2
238000001727 in vivo Methods 0.000 abstract description 2
108010060511 4-Aminobutyrate Transaminase Proteins 0.000 description 8
108090000790 Enzymes Proteins 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
206010015037 epilepsy Diseases 0.000 description 5
230000007062 hydrolysis Effects 0.000 description 5
238000006460 hydrolysis reaction Methods 0.000 description 5
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
210000003169 central nervous system Anatomy 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
206010010904 Convulsion Diseases 0.000 description 3
239000001961 anticonvulsive agent Substances 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
230000002427 irreversible effect Effects 0.000 description 3
239000000758 substrate Substances 0.000 description 3
-1 vinyl GABA Chemical compound 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
230000001773 anti-convulsant effect Effects 0.000 description 2
229960003965 antiepileptics Drugs 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000020176 deacylation Effects 0.000 description 2
238000005947 deacylation reaction Methods 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
239000002858 neurotransmitter agent Substances 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
UIUJIQZEACWQSV-UHFFFAOYSA-N succinic semialdehyde Chemical compound OC(=O)CCC=O UIUJIQZEACWQSV-UHFFFAOYSA-N 0.000 description 2
229920002554 vinyl polymer Polymers 0.000 description 2
XWILORJMRMFKPM-ZCFIWIBFSA-N (4s)-4-aminohepta-5,6-dienoic acid Chemical compound C=C=C[C@@H](N)CCC(O)=O XWILORJMRMFKPM-ZCFIWIBFSA-N 0.000 description 1
NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 description 1
NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 description 1
102000004400 Aminopeptidases Human genes 0.000 description 1
108090000915 Aminopeptidases Proteins 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
208000020401 Depressive disease Diseases 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
108010093096 Immobilized Enzymes Proteins 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
208000008238 Muscle Spasticity Diseases 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
238000003436 Schotten-Baumann reaction Methods 0.000 description 1
206010043118 Tardive Dyskinesia Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000003929 acidic solution Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
208000029650 alcohol withdrawal Diseases 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
125000005282 allenyl group Chemical group 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
150000001371 alpha-amino acids Chemical class 0.000 description 1
235000008206 alpha-amino acids Nutrition 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
108010003977 aminoacylase I Proteins 0.000 description 1
238000010171 animal model Methods 0.000 description 1
229940125681 anticonvulsant agent Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000011914 asymmetric synthesis Methods 0.000 description 1
229940125717 barbiturate Drugs 0.000 description 1
HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
239000003782 beta lactam antibiotic agent Substances 0.000 description 1
239000011942 biocatalyst Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
229940124587 cephalosporin Drugs 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
230000007423 decrease Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
150000002960 penicillins Chemical class 0.000 description 1
229960003424 phenylacetic acid Drugs 0.000 description 1
239000003279 phenylacetic acid Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
239000000047 product Substances 0.000 description 1
208000020016 psychiatric disease Diseases 0.000 description 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
201000000980 schizophrenia Diseases 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000000946 synaptic effect Effects 0.000 description 1
238000010998 test method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
102000014898 transaminase activity proteins Human genes 0.000 description 1
229960005318 vigabatrin Drugs 0.000 description 1
239000011726 vitamin B6 Substances 0.000 description 1
235000019158 vitamin B6 Nutrition 0.000 description 1
229940011671 vitamin b6 Drugs 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/007—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving acyl derivatives of racemic amines

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Health & Medical Sciences (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO19950157A 1992-07-17 1995-01-16 Fremgangsmate for enzymatisk opplosning av en racemisk blanding av stereospesifikke GABA-T-inhibitorer. NO318758B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/915,446 US5316944A (en)	1992-07-17	1992-07-17	Enzymatic resolution of a racemic mixture of gamma-amino acids using penicillin acylase
PCT/US1993/005737 WO1994002628A1 (en)	1992-07-17	1993-06-15	Enzymatic resolution of a racemic mixture of stereospecific gaba-t inhibitors

Publications (3)

Publication Number	Publication Date
NO950157D0 NO950157D0 (no)	1995-01-16
NO950157L NO950157L (no)	1995-01-16
NO318758B1 true NO318758B1 (no)	2005-05-02

Family

ID=25435755

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19950157A NO318758B1 (no)	1992-07-17	1995-01-16	Fremgangsmate for enzymatisk opplosning av en racemisk blanding av stereospesifikke GABA-T-inhibitorer.

Country Status (16)

Country	Link
US (1)	US5316944A (es)
EP (1)	EP0651821B1 (es)
JP (1)	JP3213717B2 (es)
KR (1)	KR100250100B1 (es)
AT (1)	ATE156860T1 (es)
AU (1)	AU662998B2 (es)
CA (1)	CA2136840C (es)
DE (1)	DE69313118T2 (es)
DK (1)	DK0651821T3 (es)
ES (1)	ES2106355T3 (es)
FI (1)	FI106266B (es)
GR (1)	GR3024491T3 (es)
HU (1)	HU216309B (es)
NO (1)	NO318758B1 (es)
NZ (1)	NZ253926A (es)
WO (1)	WO1994002628A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2287171A1 (en)	1997-05-01	1998-11-12	G.D. Searle & Co.	Method and apparatus for preparation of chiral beta amino acids
NL1009814C2 (nl) *	1998-08-06	2000-02-08	Dsm Nv	Werkwijze voor de bereiding van een N-geacyleerd aminonitril.
AU2001294378A1 (en) *	2000-09-08	2002-03-22	Dsm N.V.	Process for the preparation of enantiomerically enriched amines
EP1315827A1 (en)	2000-09-08	2003-06-04	Dsm N.V.	Method for the preparation of enantiomerically enriched amines
FR2853315B1 (fr) *	2003-04-04	2006-07-07	Solvay	Procede pour la fabrication de derives d'aminoacides
WO2014060925A2 (en) *	2012-10-15	2014-04-24	Mahesh Kandula	Compositions and methods for the treatment of neurological and neurodegenerative diseases
CN105777586A (zh) *	2016-04-14	2016-07-20	安徽省逸欣铭医药科技有限公司	S（+）氨己烯酸酯衍生物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2120244B (en) *	1982-05-17	1985-05-01	Merrell Toraude & Co	Aminoalkadiene derivative
DE3247764A1 (de) *	1982-12-23	1984-06-28	Ernst Leitz Wetzlar Gmbh, 6330 Wetzlar	Fotografische kamera
GB2133002B (en) *	1982-12-30	1986-01-29	Merrell Toraude & Co	Process for preparing 4-amino-5-hexenoic acid
US4636470A (en) *	1984-08-17	1987-01-13	Stauffer Chemical Company	Resolution of racemates of amino acids

1992
- 1992-07-17 US US07/915,446 patent/US5316944A/en not_active Expired - Lifetime
1993
- 1993-06-15 CA CA002136840A patent/CA2136840C/en not_active Expired - Lifetime
- 1993-06-15 EP EP93915370A patent/EP0651821B1/en not_active Expired - Lifetime
- 1993-06-15 JP JP50445294A patent/JP3213717B2/ja not_active Expired - Lifetime
- 1993-06-15 KR KR1019950700170A patent/KR100250100B1/ko not_active Expired - Lifetime
- 1993-06-15 DE DE69313118T patent/DE69313118T2/de not_active Expired - Lifetime
- 1993-06-15 ES ES93915370T patent/ES2106355T3/es not_active Expired - Lifetime
- 1993-06-15 DK DK93915370.6T patent/DK0651821T3/da active
- 1993-06-15 HU HU9500129A patent/HU216309B/hu unknown
- 1993-06-15 AU AU45377/93A patent/AU662998B2/en not_active Expired
- 1993-06-15 NZ NZ253926A patent/NZ253926A/en not_active IP Right Cessation
- 1993-06-15 AT AT93915370T patent/ATE156860T1/de active
- 1993-06-15 WO PCT/US1993/005737 patent/WO1994002628A1/en not_active Ceased
1995
- 1995-01-13 FI FI950155A patent/FI106266B/fi not_active IP Right Cessation
- 1995-01-16 NO NO19950157A patent/NO318758B1/no not_active IP Right Cessation
1997
- 1997-08-21 GR GR970402130T patent/GR3024491T3/el unknown

Also Published As

Publication number	Publication date
WO1994002628A1 (en)	1994-02-03
DE69313118T2 (de)	1997-12-11
FI106266B (fi)	2000-12-29
CA2136840A1 (en)	1994-02-03
NZ253926A (en)	1996-10-28
KR100250100B1 (ko)	2000-03-15
HU9500129D0 (en)	1995-05-29
AU662998B2 (en)	1995-09-21
HUT70466A (en)	1995-10-30
US5316944A (en)	1994-05-31
NO950157D0 (no)	1995-01-16
HU216309B (hu)	1999-06-28
GR3024491T3 (en)	1997-11-28
JPH07509132A (ja)	1995-10-12
JP3213717B2 (ja)	2001-10-02
KR950702638A (ko)	1995-07-29
DE69313118D1 (de)	1997-09-18
ES2106355T3 (es)	1997-11-01
FI950155A0 (fi)	1995-01-13
AU4537793A (en)	1994-02-14
FI950155L (fi)	1995-01-13
EP0651821A1 (en)	1995-05-10
DK0651821T3 (da)	1997-09-01
ATE156860T1 (de)	1997-08-15
NO950157L (no)	1995-01-16
EP0651821B1 (en)	1997-08-13
CA2136840C (en)	1997-01-14

Legal Events

Date	Code	Title	Description
2013-07-08	MK1K	Patent expired

Publication	Publication Date	Title
US8304252B2 (en)	2012-11-06	Stereoselective bioconversion of aliphatic dinitriles into cyano carboxylic acids
NO318758B1 (no)	2005-05-02	Fremgangsmate for enzymatisk opplosning av en racemisk blanding av stereospesifikke GABA-T-inhibitorer.
Margolin	1993	Synthesis of optically pure mechanism-based inhibitors of γ aminobutyric acid aminotransferase (GABA-T) via enzyme-catalyzed resolution
JPWO2011078172A1 (ja)	2013-05-09	光学活性３−置換グルタル酸モノアミドの製造法
Effenberger et al.	1998	Chemo-and enantioselective hydrolysis of nitriles and acid amides, respectively, with resting cells of Rhodococcus sp. C3II and Rhodococcus erythropolis MP50
Youshko et al.	2004	Application of aminoacylase I to the enantioselective resolution of α-amino acid esters and amides
WO2004003001A1 (en)	2004-01-08	Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates
WO2012176715A1 (ja)	2012-12-27	１－アミノ－２－ビニルシクロプロパンカルボン酸アミドおよびその塩、ならびにその製造方法
EP0512848A2 (en)	1992-11-11	Enzymatic resolution of alpha-tertiary carboxylic acid esters
CA2480301A1 (en)	2003-10-02	Process for preparing optically active beta-aminocarboxylic acids from racemic n-acylated beta-aminocarboxylic acids
EP2796562A1 (en)	2014-10-29	Method for producing optically-active -substituted- -amino acid
JP5595400B2 (ja)	2014-09-24	光学活性３−置換グルタル酸モノアミドの製造法
JPH01247100A (ja)	1989-10-02	光学活性カルボン酸誘導体の製造方法
Klempier et al.	2008	Nitrilase‐and Nitrile Hydratase‐Catalyzed Enantioselective Preparation of Non‐Proteinogenic Amino Acids
Acylase et al.	2010	1.5 Industrial Use of Hydrolases
Topgi	2003	Development of a Biocatalytic Process for the Resolution of (R)-and (S)-Ethyl 3-amino-4-pentynoate Isomers Using Enzyme Penicillin G Amidohydrolase
MXPA06010259A (es)	2007-04-10	Bioconversion estereoselectiva de dinitrilos alifaticos en acidos cianocarboxilicos
JPH09316044A (ja)	1997-12-09	光学活性３−クロロラクトニトリル及びそのエステル並びにそれらの製造方法